Free Trial

Envoy Medical Q1 2024 Earnings Report

Envoy Medical logo
$2.23 +0.09 (+4.21%)
(As of 03:26 PM ET)

Envoy Medical EPS Results

Actual EPS
-$0.32
Consensus EPS
-$0.19
Beat/Miss
Missed by -$0.13
One Year Ago EPS
N/A

Envoy Medical Revenue Results

Actual Revenue
$0.06 million
Expected Revenue
$0.08 million
Beat/Miss
Missed by -$20.00 thousand
YoY Revenue Growth
N/A

Envoy Medical Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

HOTTEST TRADER IN AMERICA 🔥🔥🔥 (Ad)

Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Biosciences before it skyrocketed 2,269% in less than 24 hours…

Make this one trade on Friday afternoon before the market closes.

Envoy Medical Earnings Headlines

Lake Street Sticks to Their Buy Rating for Envoy Medical (COCH)
Trump’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
Envoy Medical reports Q3 EPS (37c) vs. 13c last year.
See More Envoy Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Envoy Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Envoy Medical and other key companies, straight to your email.

About Envoy Medical

Envoy Medical (NASDAQ:COCH), a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

View Envoy Medical Profile

More Earnings Resources from MarketBeat

Upcoming Earnings